JD(S) considering buying drug developed by DRDO to distribute to public

May 18, 2021 01:22 am | Updated 01:22 am IST - Bengaluru

Former Chief Minister H.D. Kumaraswamy has told his partymen that the Janata Dal (S) was considering buying the DRDO-developed 2DG medicine for treatment of COVID-19 and distributing it among people.

During a digital interaction of party legislators on Monday, Mr. Kumaraswamy said the party would wait to understand the medicine’s efficacy in fighting COVID-19 and procure it if was found to be effective.

The legislators brought to his notice the various problems faced by the public during the lockdown, including problems in procuring foodgrains from Public Distribution System stores and the high number of deaths of youngsters being reported. A release stated that the discussion revolved around issues such as reduced testing for COVID-19, delayed or no results, confusion in vaccination, complaints of irregular supply of oxygen, and high cost of treatment of COVID-19 in private hospitals across the State.

Mobile canteen

Meanwhile, JD(S) leader and former MLC T.A. Saravana launched a free mobile canteen service near Victoria Hospital on Sunday to cater to those in need coming to the market and surrounding areas. The ‘H.D. Deve Gowda Mobile Appaji canteen’ was launched to celebrate the birthday of the former Prime Minister and distribute free food. Incidentally, Mr. Saravana had launched an Appaji Canteen at Hanumanthnagar where food was distributed for free during the lockdown last year.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.